Biography PhotoJohn F. Milligan, PhD
President and Chief Executive Officer, Gilead Sciences

Dr. Milligan joined Gilead Sciences in 1990 and was appointed Chief Executive Officer in March 2016. He was appointed President in 2008, and from 2007 to 2016 served in the role of Chief Operating Officer as well. He previously held multiple leadership roles within Gilead, including the position of Chief Financial Officer from 2002 to 2007. Dr. Milligan was named "Bay Area CFO of the Year" in 2006 for companies with revenues greater than $500 million, and he was named the top biotechnology industry CFO in the United States by Institutional Investor magazine in 2006, 2007 and 2008. He is a member of the boards of Biotechnology Industry Organization (BIO), the largest biotechnology industry organization, and Pacific Biosciences of California, Inc. He is also a Trustee of Ohio Wesleyan University. Dr. Milligan received his BA from Ohio Wesleyan University, his PhD in biochemistry from the University of Illinois and was an American Cancer Society postdoctoral fellow at the University of California at San Francisco.
NASDAQ (US Dollar)
$76.99
 Stock is Down 0.39 (0.50%)
Data as of 07/16/18 1:46 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at the Goldman Sachs 39th Annual Global Healthcare Conference

June 13, 2018 8:40 a.m. PT
Play
Gilead Sciences at Jefferies 2018 Global Healthcare Conference

June 06, 2018 10:30 a.m. ET
Play
Gilead Sciences at the Bank of America Merrill Lynch Healthcare Conference

May 16, 2018 9:20 a.m. PT
Play
2018 Annual Meeting of Stockholders

May 09, 2018 10:00 a.m. PT
Play